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Abstract
Background: With the increased use of mammography for breast cancer screening, the diagnosis
of ductal carcinoma in situ (DCIS) too has increased. This study was carried out to identify clinical
and radiological factors that may predict the presence of invasive disease within mammographically
detected microcalcifcation.
Materials and methods: A retrospective analysis of 13 vacuum-assisted breast biopsies
(Mammotome®) of mammographic calcification, which were reported to be either DCIS or invasive
disease on final histopathology, was carried out. Final surgical pathology was correlated with pre-
operative features (clinical, radiological and core histology) to predict the presence of an invasive
component.
Results: The overall sensitivity of Mammotome® was 81.8%, while for invasion it was 50%. Small
size, granular morphology, increased number and area of calcification cluster may help in predicting
invasion on mammography.
Conclusions: Mammotome® biopsy fails to detect invasion correctly in half the cases despite
ascertaining correctness of biopsy with post biopsy x-ray.
Introduction
The diagnosis rate of ductal carcinoma in situ (DCIS) has
increased markedly in recent years due to increasing use of
mammography and the widespread introduction of breast
cancer screening. Typically, 15 to 30% of lesions detected
through screening programs are DCIS [1], and most of
these present as mammographic microcalcification.
To establish a preoperative diagnosis, stereotactic auto-
mated core needle biopsy (SCNB) has been used [2-4].
However up to 20% of the lesions diagnosed as DCIS by
SCNB show foci of invasion on histopathological exami-
nation after surgical resection of these lesions [2-4]. In an
attempt to overcome shortcomings of SCNB, vacuum-
assisted needle devices such as the Mammotome® have
been introduced [5,6].
This study was performed in order to determine the value
of radiological and core biopsy features obtained using
Mammotome® in predicting invasive disease in patients
with non-palpable microcalcifications.
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Material and methods
A retrospective analysis of 95 patients undergoing vac-
uum-assisted breast biopsy (Mammotome®, Johnson &
Johnson, USA) for mammographic microcalcifcations
without an associated mammographic or clinically palpa-
ble mass was performed. Two-view mammography and
magnified view of the calcification clusters were available
for review in each case. The maximal diameter of the
lesion was measured from standard mammography and
the number of calcifications and morphology of the most
suspicious calcification within the cluster (punctate, gran-
ular or linear) were recorded from magnified views.
The lesions were biopsied with a combination of Mam-
motome® and GE Stenographer DMR® (GE Medical Sys-
tems, Buck, France) as an upright type stereotactic
mammography unit between May 2000 and December
2002. Age ranged from 28 to 77 years, with a mean of 46.9
years. Biopsy was normal in 82 (86.3%) and these sub-
jects were excluded from further analysis. The rest 13 case
forms the basis of this report. The procedure was
described previously [5,6] and the tissues obtained were
examined radiographically to determine whether the
lesions had been correctly biopsied.
All of these 13 patients underwent either therapeutic wide
local excision or simple mastectomy. Surgical histology
was reviewed and notation was made of the pathological
grade of the DCIS and the presence of invasion. Microin-
vasion, defined as the presence of invasive cells extending
less than 1 mm beyond the basement membrane, was
recorded as DCIS. The clinical, radiological and core his-
tological features of the lesions were correlated with final
surgical histology. Sensitivity of Mammotome®  biopsy
was calculated.
Results
Mammotome® biopsy diagnoses are shown in Table 1. Of
the 13 cases, 7 were diagnosed as DCIS and 4 as invasive
carcinoma, while the final diagnosis was DCIS in 5 cases
and DCIS with invasive disease in 8 cases. The sensitivity
of Mammotome® diagnosis was 81.8%, while it was 50%
for predicting invasion. The specificity cannot be calcu-
lated as the study sample constituted only histology posi-
tive cases and hence there were no true negative
diagnoses.
Out of 8 cases with invasion, 6 showed granular microcal-
cifications; however no significant relationship between
the morphology of the calcifications comprising the clus-
ter and risk of invasion could be established (Table 2).
Punctate clusters showed similar rates of invasive disease
as that of DCIS. No invasive disease was found in predom-
inantly linear clusters. The mean size of the clusters was 9
mm ranging from 1 to 30 mm. Five cases of invasive car-
cinoma had clusters <11 mm in size (Table 3), similarly 6/
8 invasive carcinoma had more than 40 clusters (Table 4).
No correlation was demonstrated between risk of invasive
disease and increasing size and number of cluster. How-
ever, there was a significant trend of increased risk of inva-




ADH 0 2 2
DCIS 5 2 7
Invasive 0 4 4
Total 5 8 13
Table 2: Calcification morphology and risk of invasion
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sion with small size, number, and increased area of the
calcification clusters (Table 5). All the cases of DCIS had
clusters <500 mm2 (P = 0.03), while only 2 cases of inva-
sive cancer were associated with <500 mm2 clusters.
Discussion
It is important to diagnose invasive disease preoperatively
as this allows patients the opportunity to undergo a single
therapeutic operation with appropriate staging and treat-
ment of the axilla. As axillary metastases without demon-
strable invasion in the primary tumor are rare, and axillary
surgery is associated with significant morbidity, routine
axillary lymph node dissection is not recommended for
DCIS [7]. Mammotome® biopsy too is found to be poor
for detecting invasion as 4/8 invasive carcinomas were
missed.
Lagios  et al., [8] have suggested that the incidence of
occult invasion in preoperatively detected DCIS is negligi-
ble in mammographic clusters below 25 mm in size, but
showed a 44% risk of invasive disease in clusters larger
than 25 mm. This has not been the case in our series
where some small mammographically detected foci of
malignant calcification have shown invasive tumors at
histology. This discrepancy may arise from the differing
sampling methods used to diagnose DCIS prior to defini-
tive surgery. Currently, the majority of microcalcifications
are assessed percutaneously. However, the area of calcifi-
cations was a good method of estimating invasive disease,
although calcification morphology and size, or numbers
of cluster calcification were not found to be useful predic-
tors of occult invasion. deRoos et al too reported no strict
association of mammographic appearance with his-
topathological grade in patients with DCIS [9]. However,
use of a poor study design and absence of final histology
on 82 cases found to be normal on Mammotome® biopsy
preclude generalization of these results.
With this limited number of cases it is noted that Mam-
motome® biopsy misses 50% of invasive disease despite
ascertaining the correctness of biopsy and hence cannot
be recommended as method of choice in non-palpable
mammographically detected microcalcification. All the
cases found to have DCIS on mammogram should
undergo wide local excision and axilla should be treated
as per institutional protocol if invasive disease is docu-
mented at final histology.
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Table 5: Area of calcification and risk of invasion
Area of calcification (mm2) DCIS Invasive
<500 5 2
>500 0 6
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